John S. Montalbano - Dec 7, 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
/s/ Tryn Stimart, attorney in fact
Stock symbol
ABCL
Transactions as of
Dec 7, 2021
Transactions value $
$0
Form type
4
Date filed
12/10/2021, 12:15 PM
Previous filing
Aug 17, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ABCL Common Shares 26K Dec 7, 2021 Direct
holding ABCL Common Shares 5K Dec 7, 2021 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share option (right to buy) Award $0 +34.3K +6.86% $0.00 534K Aug 27, 2021 Common Shares 34.3K $17.58 Direct
transaction ABCL Share option (right to buy) Award $0 +45.5K +8.52% $0.00 580K Dec 7, 2021 Common Shares 45.5K $14.55 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.